WallStreetZenWallStreetZen

NASDAQ: STTK
Shattuck Labs Inc Stock Forecast, Predictions & Price Target

Analyst price target for STTK

Based on 2 analysts offering 12 month price targets for Shattuck Labs Inc.
Min Forecast
$8.00+29.24%
Avg Forecast
$18.00+190.79%
Max Forecast
$28.00+352.34%

Should I buy or sell STTK stock?

Based on 2 analysts offering ratings for Shattuck Labs Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their STTK stock forecasts and price targets.

STTK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-14
lockedlocked$00.00+00.00%2024-05-15

1 of 1

Forecast return on equity

Is STTK forecast to generate an efficient return?
Company
-74.2%
Industry
76.4%
Market
82.5%
STTK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STTK forecast to generate an efficient return on assets?
Company
-65.31%
Industry
31.02%
STTK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STTK earnings per share forecast

What is STTK's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.56
Avg 2 year Forecast
-$1.66
Avg 3 year Forecast
-$1.91

STTK revenue forecast

What is STTK's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.3M+58.38%
Avg 2 year Forecast
$5.3M+95.21%
Avg 3 year Forecast
$4.8M+76.8%
STTK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STTK revenue growth forecast

How is STTK forecast to perform vs Biotechnology companies and vs the US market?
Company
22.98%
Industry
35.11%
Market
9.94%
STTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STTK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
STTK$6.19$18.00+190.79%Buy
XOMA$25.28$57.00+125.47%Buy
SKYE$10.48$22.00+109.92%Strong Buy
RVNC$2.82$10.00+254.61%Buy
INZY$4.74$16.40+245.99%Strong Buy

Shattuck Labs Stock Forecast FAQ

Is Shattuck Labs Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: STTK) stock is to Buy STTK stock.

Out of 2 analysts, 0 (0%) are recommending STTK as a Strong Buy, 2 (100%) are recommending STTK as a Buy, 0 (0%) are recommending STTK as a Hold, 0 (0%) are recommending STTK as a Sell, and 0 (0%) are recommending STTK as a Strong Sell.

If you're new to stock investing, here's how to buy Shattuck Labs stock.

What is STTK's earnings growth forecast for 2024-2026?

(NASDAQ: STTK) Shattuck Labs's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.88%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.82%.

Shattuck Labs's earnings in 2024 is -$85,078,000.On average, 2 Wall Street analysts forecast STTK's earnings for 2024 to be -$74,179,360, with the lowest STTK earnings forecast at -$79,885,465, and the highest STTK earnings forecast at -$68,473,256. On average, 2 Wall Street analysts forecast STTK's earnings for 2025 to be -$78,696,693, with the lowest STTK earnings forecast at -$88,444,622, and the highest STTK earnings forecast at -$68,948,764.

In 2026, STTK is forecast to generate -$90,822,166 in earnings, with the lowest earnings forecast at -$90,822,166 and the highest earnings forecast at -$90,822,166.

What is STTK's revenue growth forecast for 2024-2026?

(NASDAQ: STTK) Shattuck Labs's forecast annual revenue growth rate of 22.98% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.11%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.94%.

Shattuck Labs's revenue in 2024 is $2,715,000.On average, 1 Wall Street analysts forecast STTK's revenue for 2024 to be $204,468,750, with the lowest STTK revenue forecast at $204,468,750, and the highest STTK revenue forecast at $204,468,750. On average, 1 Wall Street analysts forecast STTK's revenue for 2025 to be $252,019,622, with the lowest STTK revenue forecast at $252,019,622, and the highest STTK revenue forecast at $252,019,622.

In 2026, STTK is forecast to generate $228,244,186 in revenue, with the lowest revenue forecast at $228,244,186 and the highest revenue forecast at $228,244,186.

What is STTK's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: STTK) forecast ROA is -65.31%, which is lower than the forecast US Biotechnology industry average of 31.02%.

What is STTK's Price Target?

According to 2 Wall Street analysts that have issued a 1 year STTK price target, the average STTK price target is $18.00, with the highest STTK stock price forecast at $28.00 and the lowest STTK stock price forecast at $8.00.

On average, Wall Street analysts predict that Shattuck Labs's share price could reach $18.00 by Jun 14, 2025. The average Shattuck Labs stock price prediction forecasts a potential upside of 190.79% from the current STTK share price of $6.19.

What is STTK's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: STTK) Shattuck Labs's current Earnings Per Share (EPS) is -$1.93. On average, analysts forecast that STTK's EPS will be -$1.56 for 2024, with the lowest EPS forecast at -$1.68, and the highest EPS forecast at -$1.44. On average, analysts forecast that STTK's EPS will be -$1.66 for 2025, with the lowest EPS forecast at -$1.86, and the highest EPS forecast at -$1.45. In 2026, STTK's EPS is forecast to hit -$1.91 (min: -$1.91, max: -$1.91).

What is STTK's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: STTK) forecast ROE is -74.2%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.